ALLURION TECHNOLOGIES, INC. (ALUR) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US02008G1022

Price
0.02 USD
Market cap
158,435.51 USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

ALLURION TECHNOLOGIES, INC. financials

Fiscal year2025
Revenue15.23 m USD
Gross profit9.57 m USD
Operating income-30.16 m USD
EBIT-28.68 m USD
Net income-28.76 m USD
Diluted EPS – continuing operations-3.81 USD

Full history since 2020, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About ALLURION TECHNOLOGIES, INC.

Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.